Latest News & Features
Big Pharma
The first woman to act as executive director of the European Medicines Agency (EMA) has officially started in the role. 18 November 2020
Americas
Daiichi Sankyo and AstraZeneca have asked the US District Court for the District of Delaware for a declaration that their breast cancer treatment does not infringe a chemotherapy patent owned by biotechnology company Seagen. 18 November 2020
Big Pharma
In response to the surge of COVID-19 infections worldwide, 18 generic drug makers have pledged to join the effort by the Medicines Patent Pool to accelerate global access to effective COVID-19 treatments via a pool for voluntary product licences. 17 November 2020
Big Pharma
German chemicals company BASF has failed to persuade the UK Intellectual Property Office that an applied-for trademark to cover agricultural chemicals is confusingly similar to its own existing trademark. 17 November 2020
Americas
American healthcare multinational Baxter has accused B.Braun of patent infringement and fraudulent misrepresentation in an on-going dispute over products used to treat acute kidney injury. 16 November 2020
Americas
The US Food and Drug Administration will today announce that it plans to grant a Chinese-owned testing company an exclusive worldwide licence for a US government-owned patent covering a diagnostic test for the rapid detection of COVID-19. 13 November 2020
Big Pharma
The European Commission has approved a fourth contract with pharmaceutical companies Pfizer and BioNTech, following their revelation that they had developed a vaccine that could potentially prevent more than 90% of people from becoming infected by COVID-19. 12 November 2020
Americas
The US Court of Appeals for the Federal Circuit has cancelled a lower court ruling holding that a Bard patent for vascular access device was both not infringed and patent-ineligible. 12 November 2020
Americas
Allied BioScience has accused its former CEO of holding the company's IP, including inventions relating to its COVID-19 antiviral disinfectant, to ransom so he can demand an unfair amount of compensation. 12 November 2020
article
Overview of Canada’s Regulatory and Intellectual Property Regimes as they apply to Biologics and Biosimilars. The Regulatory Pathway for Marketing Approval, Data Protection, Patent Linkage and Litigation, and Current Biosimilar Approvals and Applications. A Comparison to the US and European Regimes: Differences and Similarities with Canada. 12 November 2020